Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

NCT02273141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Colorectal Carcinoma
Colon Cleansing

Interventions

DRUG: NER1006, Day Before-Only Dosing
DRUG: SP+MS, Day Before-Only Dosing

Sponsor

Norgine